Skip header and navigation
Canadian Medical Association
  • CMA Policybase
  • Home
  • Help
  • Selections 0
  • Soin de santé et sécurité des patients
  • Pharmaceuticals, prescribing, cannabis, drugs
  • 2021
  • 2015
Print
Sort by Relevance Sort by Title Sort by Oldest
Gallery View List View
Refine Your Search

Narrow Results By

Topic

  • Ethics and medical professionalism 9
  • Health care and patient safety 6
  • Health human resources 3
  • Health information and e-health 3
  • Health systems, system funding and performance 11
  • Pharmaceuticals, prescribing, cannabis, drugs
  • Physician practice, compensation, forms 5
  • Population health, health equity, public health 24

Policy Type

  • Parliamentary submission 1
  • Policy document 2
  • Policy endorsement 1
  • Response to consultation 1

Year

  • 2022 1
  • 2021
  • 2020 2
  • 2019 5
  • 2018 10
  • 2017 9
  • 2016 7
  • 2015
  • 2014 8
  • 2013 2
  • 2012 4
  • 2011 1
  • Advanced Search
  • Help

5 records – page 1 of 1.

Prev Next
Select Title Policy Type Year
EspAddText
EspRemoveText
Policy Brief: CSAM-SMCA in Support of the Decriminalization of Drug Use and Possession for Personal Use Policy endorsement 2021
EspAddText
EspRemoveText
CMA's Response to Health Canada's Public Consultation Guide to New Authorities in reference to Bill C-17, Protecting Canadians from Unsafe Drugs Act (Vanessa's Law) Response to consultation 2015
EspAddText
EspRemoveText
Complementary and alternative medicine (update 2015) Policy document 2015
EspAddText
EspRemoveText
Harms associated with opioids and other psychoactive prescription drugs Policy document 2015
EspAddText
EspRemoveText
Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act) Parliamentary submission 2015
  • Privacy
  • Terms & Conditions
  • Accessibility
  • Contact

© 2023 Canadian Medical Association